Track the Dr. Lal Path Labs Ltd. share price and the full management transaction log of the company, a listed equity based in India. Shares are quoted on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Dr. Lal Path Labs Ltd. has logged 877 insider filings. Market capitalisation: €273.4bn. The latest transaction was filed on 1 May 2026 (Purchase). Among the most active insiders: Dr. Lal PathLabs Employees Welfare Trust. Every trade is openly available.
877
Insider Decl.
0
Thresholds
€12m
355 ops.
Buy Volume
€87m
521 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Dr. Lal Path Labs Ltd. Buy (bullish), based on 26 analysts. Average price target: ₹1,686.00.
18Σ signal
Buys €12m€87m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 8,178 of 25,571 companies
60.7
score / 100
Value
34
Quality
88
FCF yld1.6%
Earn yld1.8%
EV/EBITDA33.1x
ROE21%
Gross mgn81%
Net mgn18%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.